KMT2A and acute lymphoblastic leukemia: The hub genes closely associated with MLL-r ALL were further confirmed in the data of Therapeutically Applicable Research to Generate Effective Treatments (TARGET) ALL (Phase I), ALL cell lines, and childhood ALL patients.